Nausea is one of the most common side effects experienced when starting GLP-1 receptor agonist medications for type 2 diabetes or weight management
T2DM with chronic kidney disease In individuals with T2DM, CKD significantly heightens CV risk and mortality, even with mild albuminuria or slight decreases in estimated glomerular filtration rate (eGFR)
Journal (Molecules, Nov 19, 2014, 19(11), 1906619077)
Tirzepatide acts on both GLP-1 and GIP receptors, providing a broader metabolic effect compared to GLP-1 alone
Vilsbll T, Knop FK, Krarup T et al
Stabilizers Stabilizers- Picture courtesy: Sigma Aldrich Heres a fact: growth hormone proteins can clump together (aggregate) during storage and transportation, thereby losing their potency when injected